Published in Eur J Neurol on December 29, 2009
Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain (2012) 1.99
Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson's disease. Eur J Nucl Med Mol Imaging (2014) 0.84
Parkinson's disease subtypes show a specific link between dopaminergic and glucose metabolism in the striatum. PLoS One (2014) 0.82
The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regions. J Neurol (2016) 0.80
SPECT molecular imaging in Parkinson's disease. J Biomed Biotechnol (2012) 0.79
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype. J Neural Transm (Vienna) (2015) 0.78
Thyroid hormone level is associated with motor symptoms in de novo Parkinson's disease. J Neurol (2015) 0.77
Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism. Neuroradiology (2016) 0.77
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease. J Neurol (2014) 0.76
Rest tremor revisited: Parkinson's disease and other disorders. Transl Neurodegener (2017) 0.75
Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype. PLoS One (2017) 0.75
Structural Brain Alterations in Motor Subtypes of Parkinson's Disease: Evidence from Probabilistic Tractography and Shape Analysis. PLoS One (2016) 0.75
On the Complexity of Brain Disorders: A Symptom-Based Approach. Front Comput Neurosci (2016) 0.75
Quantification of neural reflex and muscular intrinsic contributions to parkinsonian rigidity. Exp Brain Res (2016) 0.75
Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation (2001) 3.14
White matter hyperintensities in Parkinson's disease. Clinical correlations. Arch Neurol (1995) 2.30
Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med (1996) 1.98
The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol (1999) 1.85
Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol (2004) 1.80
Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes (2001) 1.76
IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study. Neurology (2003) 1.60
Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty. Eur Heart J (2003) 1.58
Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients. Neurology (2002) 1.51
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology (2008) 1.50
Clozapine in Huntington's chorea. Neurology (1994) 1.50
White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients. Cephalalgia (1994) 1.49
Identification of Hürthle cell tumor by single-injection, double-phase scintigraphy with technetium-99m-sestamibi. J Nucl Med (1995) 1.45
Hypertensive left ventricular remodeling and ACE-gene polymorphism. Cardiovasc Res (1999) 1.41
Calcium antagonist isradipine improves abnormal endothelium-dependent vasodilation in never treated hypertensive patients. Cardiovasc Res (1999) 1.39
A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes (1984) 1.39
Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest (1993) 1.35
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol (2000) 1.30
REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study. Neurol Sci (2005) 1.30
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology (1999) 1.25
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol (2013) 1.24
Effects of whole-body vibration exercise on the endocrine system of healthy men. J Endocrinol Invest (2004) 1.23
Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia. J Clin Invest (1984) 1.21
A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry (2004) 1.20
The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity. Diabetologia (1991) 1.16
Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. The Italian Collaborative Group for the Study of Psychopathological Factors in Primary Headaches. Cephalalgia (1999) 1.13
Paroxetine in Parkinson's disease: effects on motor and depressive symptoms. Neurology (2000) 1.11
Demonstration of a dawn phenomenon in normal human volunteers. Diabetes (1984) 1.10
Dietary habits in type II diabetes mellitus: how is adherence to dietary recommendations? Eur J Clin Nutr (2007) 1.07
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology (2005) 1.07
Captopril radionuclide test in renovascular hypertension: a European multicentre study. European Multicentre Study Group. Eur J Nucl Med (1993) 1.06
Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease. Mov Disord (2001) 1.05
Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study. Mov Disord (2001) 1.03
Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients. Hypertension (1998) 1.02
Spinocerebellar ataxia type 2 in southern Italy: a clinical and molecular study of 30 families. J Neurol (1999) 1.00
CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease. Brain Res Bull (2008) 0.99
Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand (2007) 0.98
Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients. Neurol Sci (2001) 0.97
Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1988) 0.97
Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients. Cytogenet Cell Genet (1999) 0.97
SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study. Clin Neuropharmacol (2001) 0.96
From mild cognitive impairment to dementia: a prevalence study in a district of Tuscany, Italy. Acta Neurol Scand (2005) 0.96
Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci (2001) 0.96
The relationship between cerebral vascular disease and parkinsonism: The VADO study. Parkinsonism Relat Disord (2012) 0.96
Comparison of endothelial function evaluated by strain gauge plethysmography and brachial artery ultrasound. Atherosclerosis (2001) 0.95
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. J Clin Invest (1992) 0.95
Nocturnal blood glucose control in type I diabetes mellitus. Diabetes Care (1993) 0.94
Contribution of amino acids and insulin to protein anabolism during meal absorption. Diabetes (1996) 0.93
Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients. Atherosclerosis (2000) 0.93
Clinical diagnosis of multiple system atrophy: level of agreement between Quinn's criteria and the consensus conference guidelines. Acta Neurol Scand (2001) 0.92
A case of sarcoidosis presenting as a non-specific intramedullary lesion. Eur J Neurol (2007) 0.92
The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy. Atherosclerosis (2008) 0.92
Acute and chronic effects of clozapine in essential tremor. Mov Disord (1999) 0.92
Lack of glucagon response in glucose counter-regulation in type 1 (insulin-dependent) diabetics: absence of recovery after prolonged optimal insulin therapy. Diabetologia (1982) 0.92
Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon. Diabetologia (1986) 0.91
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany. Neurol Sci (2007) 0.91
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. J Endocrinol Invest (2006) 0.91
Stage of change and motivation to healthy diet and habitual physical activity in type 2 diabetes. Acta Diabetol (2014) 0.91
Clinical outcome and magnetic resonance imaging of carbon monoxide intoxication. A long-term follow-up study. Ital J Neurol Sci (1999) 0.91
Improvement of motor function in early Parkinson disease by safinamide. Neurology (2004) 0.91
The genetics of ataxia: through the labyrinth of the Minotaur, looking for Ariadne's thread. J Neurol (2014) 0.91
Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients. Circulation (1999) 0.90
Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors. Q J Nucl Med Mol Imaging (2008) 0.90
Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease. Hum Genet (1997) 0.90
Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia (1990) 0.90
Paraneoplastic choreic syndrome during non-Hodgkin's lymphoma. Mov Disord (2000) 0.89
The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus. N Engl J Med (1988) 0.89
Mitochondrial DNA rearrangements in young onset parkinsonism: two case reports. J Neurol Neurosurg Psychiatry (2001) 0.88
A whole-brain analysis in de novo Parkinson disease. AJNR Am J Neuroradiol (2008) 0.88
The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors. Diabetes (1983) 0.88
The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects. Curr Alzheimer Res (2009) 0.88
Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy. Parkinsonism Relat Disord (2004) 0.87
Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography. Arch Neurol (2001) 0.87
Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study. J Neural Transm (Vienna) (2004) 0.86
Role of hepatic autoregulation in defense against hypoglycemia in humans. J Clin Invest (1985) 0.86
Amantadine in Huntington's disease: open-label video-blinded study. Neurol Sci (2002) 0.86
Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules. Results of a three-year multicenter prospective randomized trial. J Clin Endocrinol Metab (2014) 0.86
Gender differences in basal protein kinetics in young adults. J Clin Endocrinol Metab (1998) 0.86
Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports. Ital J Neurol Sci (1983) 0.86
Multidisciplinary lifestyle intervention in the obese: its impact on patients' perception of the disease, food and physical exercise. Nutr Metab Cardiovasc Dis (2012) 0.86
Difficult asthma: possible association with rhinosinusitis. Pediatr Allergy Immunol (2007) 0.85
Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia. J Neural Transm (Vienna) (2006) 0.85
Myopathic involvement in two cases of Hallervorden-Spatz disease. Brain Dev (1996) 0.85
A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults. J Clin Endocrinol Metab (1998) 0.85
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus. Eur J Clin Pharmacol (1992) 0.85